diSArm clinical trial is that our phages injected intravenously can home in to the site of infection, penetrate biofilms, infect, and lyse S. aureus. Many deaths post flu, and most likely also ...

In experiments, researchers showed that the disease-spreading insects couldn’t resist the sweet smell of a fungus that infected and killed them.

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

In a separate 2024 study, researchers also made mice temporarily transparent. The study, published in Science, showed that ...

Every time a doctor orders a CT scan, or a child receives a lifesaving vaccine, or your phone’s GPS corrects itself by the ...